Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions.

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT03721614

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03721614
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03721614. Randomized; no masking; primary purpose treatment. Start 2019-09-15 (anticipated); primary completion 2021-12-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions.
Acronym
Morph RCT-1
Intervention (Device)
BioMime™ Morph - Sirolimus Eluting Coronary Stent System
Intervention (Device)
Xience family Everolimus Coronary Stent Systems
Lead sponsor
Meril Life Sciences Pvt. Ltd. (class: industry)

Record details

Record id
cardio:ct-nct03721614
Content hash
a1cc186eab21c29dbf27dd592e6df5a4fb426d518d7c22837f5c2a731a48ae61